Current smoking status is associated with reduced sputum immunoglobulin M and G expression in COPD

Steven P. Cass,Yuqiong Yang,Jing Xiao,Joshua J.C. McGrath,Matthew F. Fantauzzi,Danya Thayaparan,Fengyan Wang,Zhenyu Liang,Fei Long,Christopher S. Stevenson,Rongchang Chen,Martin R. Stampfli
DOI: https://doi.org/10.1183/13993003.02338-2019
IF: 24.3
2020-09-03
European Respiratory Journal
Abstract:The relationship between smoking status and total immunoglobulin levels in patients with COPD is not fully understood. Decreased immunoglobulin levels have been observed in patients with COPD [1–4], a disease largely attributed to current or former smoking, and cigarette smokers [5, 6]. These studies focused predominately on serum (systemic) or salivary (upper respiratory tract) immunoglobulins. Levels of immunoglobulins in induced sputum, a more direct measure of airway immunoglobulins, are less well studied. Given the vital role immunoglobulins perform in microbial defence and tissue homeostasis, we assessed airway immunoglobulins in induced sputum of smokers and patients with COPD.
respiratory system
What problem does this paper attempt to address?
### The Problem the Paper Aims to Address This paper aims to explore the relationship between current smoking status and the levels of immunoglobulins (IgM and IgG) in the sputum of patients with chronic obstructive pulmonary disease (COPD). Specifically, the study found: - In patients with mild to moderate COPD, current smoking status is associated with reduced levels of total IgM and IgG in the sputum. - This reduction in immunoglobulin levels is not related to the use of inhaled corticosteroids. Through this study, the authors hope to better understand the impact of smoking on the respiratory immune function of COPD patients and provide a foundation for further investigation into mechanisms and potential therapeutic strategies.